Results 201 to 210 of about 49,156 (260)
Calcium supplementation for prevention of pre-eclampsia in high-risk women: study protocol for a randomised triple-blind placebo-controlled trial (CaPE). [PDF]
TrialsMeher S +14 more
europepmc +1 more source
Knowledge of Pre-Eclampsia and Its Risk Factors Among Pregnant Women Attending Antenatal Care in Lango Sub-Region, Northern Uganda. [PDF]
Int J Womens HealthNanyonga JK, Nakaziba R.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lancet, The, 2021
(Abstracted from Lancet 2021;398:341–354) Preeclampsia affects approximately 3% to 5% of all pregnancies and is a substantial contributor to maternal morbidity and mortality. The hallmark features are hypertension and proteinuria, and significant complications of multiorgan injury include eclamptic seizures, pulmonary edema, epigastric pain ...
Lucy C Chappell +2 more
exaly +3 more sources
(Abstracted from Lancet 2021;398:341–354) Preeclampsia affects approximately 3% to 5% of all pregnancies and is a substantial contributor to maternal morbidity and mortality. The hallmark features are hypertension and proteinuria, and significant complications of multiorgan injury include eclamptic seizures, pulmonary edema, epigastric pain ...
Lucy C Chappell +2 more
exaly +3 more sources
Lancet, The, 2016
Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteroplacental dysfunction, or fetal growth restriction. When
Ben W Mol +2 more
exaly +5 more sources
Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteroplacental dysfunction, or fetal growth restriction. When
Ben W Mol +2 more
exaly +5 more sources
Lancet, The, 2010
Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It is a pregnancy-specific disease characterised by de-novo development of concurrent hypertension and proteinuria, sometimes progressing into a multiorgan cluster of varying clinical features.
+2 more
exaly +4 more sources
Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It is a pregnancy-specific disease characterised by de-novo development of concurrent hypertension and proteinuria, sometimes progressing into a multiorgan cluster of varying clinical features.
+2 more
exaly +4 more sources
The American Journal of Surgery, 1951
Abstract 1. 1. Eclampsia is a major cause of maternal death. 2. 2. Good prenatal care will eliminate all but a small number of eclamptic deaths. 3. 3. Phlebotomy is not indicated. 4. 4. Home treatment is hazardous except in the mildest cases of pre-eclampsia. 5. 5. Inhalation anesthesia should be avoided. 6. 6.
C A, GORDON +2 more
openaire +2 more sources
Abstract 1. 1. Eclampsia is a major cause of maternal death. 2. 2. Good prenatal care will eliminate all but a small number of eclamptic deaths. 3. 3. Phlebotomy is not indicated. 4. 4. Home treatment is hazardous except in the mildest cases of pre-eclampsia. 5. 5. Inhalation anesthesia should be avoided. 6. 6.
C A, GORDON +2 more
openaire +2 more sources
The Lancet, 2005
Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of ...
Sibai, B., Dekker, G., Kupferminc, M.
openaire +3 more sources
Pre-eclampsia is a major cause of maternal mortality (15-20% in developed countries) and morbidities (acute and long-term), perinatal deaths, preterm birth, and intrauterine growth restriction. Key findings support a causal or pathogenetic model of superficial placentation driven by immune maladaptation, with subsequently reduced concentrations of ...
Sibai, B., Dekker, G., Kupferminc, M.
openaire +3 more sources
Tropical Doctor, 1978
This chapter will consider the conditions of pre-eclampsia, eclampsia and superimposed pre-eclampsia on chronic hypertensive vascular disease and chronic renal disease. The term ‘toxaemia of pregnancy’ is no longer in use. In the past it was used to include a number of conditions with obscure aetiology in which it was presumed that some toxic substance
openaire +3 more sources
This chapter will consider the conditions of pre-eclampsia, eclampsia and superimposed pre-eclampsia on chronic hypertensive vascular disease and chronic renal disease. The term ‘toxaemia of pregnancy’ is no longer in use. In the past it was used to include a number of conditions with obscure aetiology in which it was presumed that some toxic substance
openaire +3 more sources
Etiology of Pre-Eclampsia-Eclampsia
American Journal of Obstetrics and Gynecology, 1955Abstract In the normal pregnant patient when compared with the nonpregnant, the following significant changes are noted: Muscle: The water content is unchanged. Sodium is increased. Potassium remains unchanged. The Na:K ratio is increased. The nitrogen content is unchanged. Skin: Sodium and water are increased. Potassium is unchanged. The Na:K ratio
William J. Dieckmann, R.E. Pottinger
openaire +1 more source